[Preventive treatment for migraine] - PubMed (original) (raw)
[Article in Dutch]
Affiliations
- PMID: 20699036
Review
[Preventive treatment for migraine]
[Article in Dutch]
Wim M Mulleners et al. Ned Tijdschr Geneeskd. 2010.
Abstract
Migraine patients who experience an average of 2 or more attacks per month are eligible for preventive treatment as well as treatment for acute attacks. The decision to offer preventative treatment is also made on the basis of the average attack duration, severity of the attacks, and response to attack treatment. Prior to initiating preventive treatment, the average attack frequency per month should be assessed, preferably by means of a headache diary over a number of months, as attack frequency is extremely variable. None of the currently available preventive drugs, such as beta-blockers, sodium valproate, topiramate and candesartan, were developed specifically for treating migraine, but were all originally intended for other indications. 50% of the migraine patients receiving preventive treatment can expect a 50% reduction in attacks, and the remaining attacks often seem to be less severe. The effects of the drugs are often unpredictable per individual, and side-effects frequently lead to early discontinuation of treatment. Drugs usually prescribed for cardiovascular disorders are often used. In the case of a disorder such as migraine with a high burden of disability, patients with cardiovascular or pulmonary comorbidity should receive medication that is optimally adjusted for both indications.
Similar articles
- Preventive treatment of migraine.
Silberstein SD. Silberstein SD. Rev Neurol Dis. 2005 Fall;2(4):167-75. Rev Neurol Dis. 2005. PMID: 16622394 Review. - [Prophylactic treatments of migraine].
Massiou H. Massiou H. Rev Neurol (Paris). 2000;156 Suppl 4:4S79-86. Rev Neurol (Paris). 2000. PMID: 11139754 Review. French. - Drug treatment of migraine: Part II. Preventive therapy.
Noble SL, Moore KL. Noble SL, et al. Am Fam Physician. 1997 Dec;56(9):2279-86. Am Fam Physician. 1997. PMID: 9402813 Review. - [Prophylactic treatment of migraine].
Le Jeunne C. Le Jeunne C. Pathol Biol (Paris). 2000 Sep;48(7):690-6. Pathol Biol (Paris). 2000. PMID: 11072649 Review. French. - Pharmacological prevention of migraine.
Rapoport AM. Rapoport AM. Clin Neurosci. 1998;5(1):55-9. Clin Neurosci. 1998. PMID: 9523060 Review.
Cited by
- CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs.
Vandervorst F, Van Deun L, Van Dycke A, Paemeleire K, Reuter U, Schoenen J, Versijpt J. Vandervorst F, et al. J Headache Pain. 2021 Oct 25;22(1):128. doi: 10.1186/s10194-021-01335-2. J Headache Pain. 2021. PMID: 34696711 Free PMC article. - Manual therapy as a prophylactic treatment for migraine: design of a randomized controlled trial.
Amons AL, Castien RF, van der Wouden JC, De Hertogh W, Dekker J, van der Horst HE. Amons AL, et al. Trials. 2019 Dec 27;20(1):785. doi: 10.1186/s13063-019-3937-8. Trials. 2019. PMID: 31881911 Free PMC article. - The Effectiveness of Mindfulness-Based Stress Reduction on Perceived Pain Intensity and Quality of Life in Patients With Chronic Headache.
Bakhshani NM, Amirani A, Amirifard H, Shahrakipoor M. Bakhshani NM, et al. Glob J Health Sci. 2015 Aug 6;8(4):142-51. doi: 10.5539/gjhs.v8n4p142. Glob J Health Sci. 2015. PMID: 26573025 Free PMC article. Clinical Trial. - Prophylactic treatment of migraine; the patient's view, a qualitative study.
Dekker F, Knuistingh Neven A, Andriesse B, Kernick D, Reis R, Ferrari MD, Assendelft WJ. Dekker F, et al. BMC Fam Pract. 2012 Mar 9;13:13. doi: 10.1186/1471-2296-13-13. BMC Fam Pract. 2012. PMID: 22405186 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical